Join
Live feed
·
PRReleasevia Quantisnow
Assembly Biosciences Inc. logo

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

ByQuantisnow·Wall Street's wire, on your screen.
ASMB· Assembly Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ASMB (Assembly Biosciences Inc.) and more on Quantisnow.